Arturo LoAIza-Bonilla, Systemwide Chief of Hematology and Oncology at St. Luke’s University Health Network, and Co-Founder and Chief Medical AI Officer (CMAIO) of Massive Bio, shared a post on LinkedIn:
“Clinical trials don’t fail because of science. They fail in the last mile.
At the NCODA Spring Forum 2026, I have the privilege of moderating
‘From Referral to Randomization: Using AI to Close Clinical Trial Enrollment Gaps’
With outstanding colleagues: Caroline Merillat, Katie Goodman, R. Donald Harvey, PharmD, FCCP, FHOPA, FASCO
Key takeaway:
- Oncology is not a matching problem.
- It is an orchestration problem.
- AI, when deployed correctly, does not just identify patients.
It connects workflows, teams, and timing to move patients from:
Awareness – referral – screening – randomization.
This is the shift: From AI as a tool – AI as infrastructure for clinical research.
That is how we close the enrollment gap.”
Other articles about AI on OncoDaily.